DE3170937D1 - 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them - Google Patents

2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them

Info

Publication number
DE3170937D1
DE3170937D1 DE8181107104T DE3170937T DE3170937D1 DE 3170937 D1 DE3170937 D1 DE 3170937D1 DE 8181107104 T DE8181107104 T DE 8181107104T DE 3170937 T DE3170937 T DE 3170937T DE 3170937 D1 DE3170937 D1 DE 3170937D1
Authority
DE
Germany
Prior art keywords
ylalkyl
benzodioxan
imidazoles
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8181107104T
Other languages
English (en)
Inventor
Arthur F Kluge
Arthur M Strosberg
Roger L Whiting
George A Christie
David L Waterbury
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntex USA LLC
Original Assignee
Syntex USA LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex USA LLC filed Critical Syntex USA LLC
Application granted granted Critical
Publication of DE3170937D1 publication Critical patent/DE3170937D1/de
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/201,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
DE8181107104T 1980-09-10 1981-09-09 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them Expired DE3170937D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/185,832 US4302469A (en) 1980-09-10 1980-09-10 2-(1,4-Benzodioxan-2-ylalkyl)imidazoles useful as antidepressants

Publications (1)

Publication Number Publication Date
DE3170937D1 true DE3170937D1 (en) 1985-07-18

Family

ID=22682624

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8181107104T Expired DE3170937D1 (en) 1980-09-10 1981-09-09 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them

Country Status (17)

Country Link
US (1) US4302469A (de)
EP (1) EP0047531B1 (de)
JP (1) JPS5750989A (de)
KR (1) KR830007626A (de)
AT (1) ATE13765T1 (de)
AU (1) AU541413B2 (de)
CA (1) CA1173044A (de)
DE (1) DE3170937D1 (de)
DK (1) DK400781A (de)
ES (1) ES8205791A1 (de)
FI (1) FI812804L (de)
HU (1) HU186781B (de)
IL (1) IL63782A (de)
NO (1) NO813065L (de)
NZ (1) NZ198321A (de)
YU (1) YU217181A (de)
ZA (1) ZA816259B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
US4402967A (en) * 1981-04-23 1983-09-06 Syntex (U.S.A.) Inc. Method for lowering intraocular pressure
US4436914A (en) * 1981-08-03 1984-03-13 Kluge Arthur F Benzodioxane-imidazoline compounds as antihypertensives
US4567264A (en) * 1983-05-18 1986-01-28 Syntex (U.S.A.) Inc. Cardioselective aryloxy- and arylthio- hydroxypropylene-piperazinyl acetanilides which affect calcium entry
FI833224A (fi) * 1983-09-09 1985-03-10 Farmos Oy Foerfarande foer framstaellning av ett terapeutiskt aktivt aemne.
US4634714A (en) * 1983-12-01 1987-01-06 American Home Products Corporation Inhibition of prolactin release by a benzodioxinylimidazoline derivative
GB2167408B (en) * 1984-11-23 1988-05-25 Farmos Oy Substituted imidazole derivatives and their preparation and use
US4943311A (en) * 1988-05-09 1990-07-24 Uniroyal Chemical Company, Inc. Azole derivatives of spiroheterocycles
IL95760A0 (en) * 1989-09-27 1992-05-25 Rhone Poulenc Sante Imidazole derivatives,their preparation and pharmaceutical compositions containing the same
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
US6162455A (en) * 1997-01-22 2000-12-19 American Cyanamid Company Method for increasing lean meat, improving the lean meat to fat ratio and improving amino acid utilization in warm-blooded animals
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
AU2004281750A1 (en) * 2003-10-14 2005-04-28 Wyeth Use of adrenergic alphaze antagonists for the treatment of vasomotor symptoms

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA731147A (en) 1966-03-29 Charles E. Frosst And Co. 1:4 benzodioxan derivatives
US2979511A (en) * 1959-03-25 1961-04-11 Olin Mathieson Certain 1, 4-benzodioxanyl imidazolines and corresponding pyrimidines and process
US3360529A (en) * 1962-01-29 1967-12-26 Smith Kline French Lab Guanidinoalkylbenzodioxan derivatives
GB1094982A (en) 1963-05-08 1967-12-13 Ward Blenkinsop & Co Ltd 1,4-benzodioxanes
BE643853A (de) 1964-02-20 1964-08-14
US3829411A (en) * 1972-03-29 1974-08-13 Eastman Kodak Co Thiadiazolyl-azo-indole compounds
GB1411531A (en) * 1972-10-24 1975-10-29 Lafon Labor Amino derivatives of 1,4-benzodioxan
GB1457038A (en) * 1973-10-23 1976-12-01 Lafon Labor Amino derivatives of 1,4-benzodioxan
GB1520801A (en) 1975-01-16 1978-08-09 Lafon Labor Benzodioxanyl and benzofuranylmethylamines
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans

Also Published As

Publication number Publication date
IL63782A0 (en) 1981-12-31
ES505329A0 (es) 1982-08-16
FI812804L (fi) 1982-03-11
NZ198321A (en) 1985-07-12
JPS5750989A (en) 1982-03-25
DK400781A (da) 1982-03-11
KR830007626A (ko) 1983-11-04
YU217181A (en) 1983-10-31
ZA816259B (en) 1983-04-27
AU541413B2 (en) 1985-01-10
ATE13765T1 (de) 1985-06-15
AU7509481A (en) 1982-03-18
EP0047531B1 (de) 1985-06-12
HU186781B (en) 1985-09-30
IL63782A (en) 1984-03-30
NO813065L (no) 1982-03-11
US4302469A (en) 1981-11-24
CA1173044A (en) 1984-08-21
ES8205791A1 (es) 1982-08-16
EP0047531A1 (de) 1982-03-17

Similar Documents

Publication Publication Date Title
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
ES486349A1 (es) Procedimiento para la preparacion de 5-(2-imidazolin-2-il)- aminopirimidinas
ES8203883A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
DE3170937D1 (en) 2-(1,4-benzodioxan-2-ylalkyl) imidazoles, their preparation and pharmaceutical compositions containing them
AU557954B2 (en) Diethylaminoalkoxy-benzhydrol derivatives
AU558261B2 (en) Dialkylaminoalkyoxybenzylalcohol derivatives
DE3070768D1 (en) 1-((substituted-naphthyl)ethyl)-imidazole derivatives, pharmaceutical compositions containing them and methods of making them
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES8305758A1 (es) "un procedimiento para la preparacion de 2-(1,4-benzodioxan-2-il-metil)-imidazolina".
ES476354A1 (es) Procedimientos para la obtencion de nuevos derivados de ari-laminoimidazolina.
IL87796A0 (en) Substituted 3-aminosydnonimines,their preparation and pharmaceutical compositions containing them
ES8600203A1 (es) Procedimiento de preparacion de nuevos derivados aminoetoxibencilalcoholicos y de sus sales de adicion acidas y amonicas cuaternarias
ES2009283A6 (es) Procedimiento para preparar nuevos aminoacilatos de glicerol-acetal.
GB2022583A (en) New ionic polyiodo benzene derivatives useful as X-ray contrast media

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee